Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma Foods International CoTSE:2929 +1.36%63 Return-on-Tangible-Equity is 2.83% as of Jan. 2026, which is 74% below its 10-year median of 11.02. GuruFocus rates TSE:2929 with a GF Score™ of 63/100 and a GF Value™ of 円1,051.63 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 899 Drug Manufacturers companies, Pharma Foods International Co ranks worse than 81.54% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Pharma Foods International Co's annualized net income for the quarter that ended in Jan. 2026 was 円268 Mil. Pharma Foods International Co's average shareholder tangible equity for the quarter that ended in Jan. 2026 was 円9,466 Mil. Therefore, Pharma Foods International Co's annualized Return-on-Tangible-Equity for the quarter that ended in Jan. 2026 was 2.83%.
The historical rank and industry rank for Pharma Foods International Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:2929'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -10.52 Med: 11.02 Max: 59.16
Current: -10.52
During the past 13 years, Pharma Foods International Co's highest Return-on-Tangible-Equity was 59.16%. The lowest was -10.52%. And the median was 11.02%.
TSE:2929's Return-on-Tangible-Equity is ranked worse than 81.54% of 899
companies
in the Drug Manufacturers industry
Industry Median: 7.95
vs TSE:2929: -10.52
Pharma Foods International Co (TSE:2929) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Pharma Foods International Co Return-on-Tangible-Equity Related Terms
Pharma Foods International Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Foods International Co Return-on-Tangible-Equity Chart
TSE:2929 vs ZTS, UTHR: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Foods International Co Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Pharma Foods International Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jan. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 2.83% mean?
Pharma Foods International Co (TSE:2929) has a Return-on-Tangible-Equity of 2.83% as of Jan. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Pharma Foods International Co and its competitors. This is 74% below median its historical median of 11.02. According to the industry distribution chart, Pharma Foods International Co ranks #733 out of 899 companies in the Drug Manufacturers industry, placing it in the top 81.5%.
Is Pharma Foods International Co's Return-on-Tangible-Equity too high?
Pharma Foods International Co's current Return-on-Tangible-Equity of 2.83% is 74% below median its 10-year median of 11.02. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.95. Pharma Foods International Co's value of 2.83% is 64.4% below this industry median. Based on the distribution chart, Pharma Foods International Co ranks #733 out of 899 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Pharma Foods International Co has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pharma Foods International Co's Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Pharma Foods International Co ranks #733 out of 899 companies for Return-on-Tangible-Equity. This places Pharma Foods International Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.95. Pharma Foods International Co's value of 2.83% is 64.4% below this benchmark. While the company's 10-year median is 11.02 vs. the industry median of 7.95, Pharma Foods International Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.95, based on 899 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Foods International Co's current Return-on-Tangible-Equity of 2.83% is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Pharma Foods International Co and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Foods International Co's current Return-on-Tangible-Equity is 2.83%, which is 74% below median its own 10-year median of 11.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Foods International Co stock overvalued right now?
Based on GuruFocus' analysis, Pharma Foods International Co (TSE:2929) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,051.63, compared to a current price of 円596.00 — trading 43.3% below its estimated fair value. The current Return-on-Tangible-Equity is 2.83%, which is 74% below median its 10-year median of 11.02 and 64.4% below the Drug Manufacturers industry median of 7.95. Pharma Foods International Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Pharma Foods International Co (TSE:2929), the current Return-on-Tangible-Equity is 2.83% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Foods International Co (TSE:2929) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Foods International Co stock appears to be undervalued.
The current stock price of 円596.00 is trading 43.3% below its estimated GF Value™ of 円1,051.63.
GuruFocus considers Pharma Foods International Co to be Possible Value Trap.
Key valuation signals for TSE:2929:
Return-on-Tangible-Equity: 2.83% (74% below median its 10-year median of 11.02)
GF Value™: 円1,051.63 vs. price of 円596.00 (43.3% below fair value)
Industry Position: 64.4% below the Drug Manufacturers median (#733 of 899)
No single metric tells the full story. See the TSE:2929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Foods International Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2929 has been successfully added to your 
